ORMP Oramed Pharmaceuticals Inc.
Fundamentals / CIK 0001176309 / USDOramed Pharmaceuticals Inc. reported $2.00M in revenue and net income of $144.9M for the fiscal year ended December 31, 2025, with a 0.7% gross margin and a -810.1% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ORMP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$2.00M Dec 31, 2025
-
Operating Income FY 2025-$16.20M -810.1% margin
-
Net Income FY 2025$144.9M 7244.2% net margin
-
Diluted EPS FY 2025$3.37 Split-adjusted
-
Free Cash Flow FY 2025-$3.17M -158.4% FCF margin
-
Cash & ST Investments Sep 30, 2026$583K Total debt: $1.53M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.00M | -- | $1.34M | $2.70M | $2.70M | $2.71M | $2.70M | $2.45M | $2.46M | $641K |
| Cost of Revenue | $1.99M | -- | -- | -- | -- | -- | $90K | -$86K | $187K | $490K |
| Gross Profit | $13K | -- | -- | -- | -- | -- | $2.61M | $2.54M | $2.27M | $151K |
| Research & Development | $6.38M | $6.32M | $8.97M | $27.64M | $20.99M | $10.23M | $13.52M | $11.98M | $10.28M | $7.71M |
| Operating Income | -$15.09M | -$12.78M | -$15.77M | -$40.60M | -$24.22M | -$11.76M | -$14.63M | -$13.53M | -$10.77M | -$10.01M |
| EBITDA | -$14.97M | -$12.59M | -$15.57M | -$40.54M | -$24.15M | -$11.75M | -$14.62M | -$13.52M | -$10.77M | -$10.01M |
| Interest Income | $2.37M | $4.98M | $10K | $100K | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | $853K | $2.04M | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | $75.32M | -$15.92M | $5.09M | -$37.66M | -- | -$11.51M | -$14.05M | -$12.73M | -$10.08M | -$9.63M |
| Income Tax Expense | $11.31M | $3.18M | -- | $100K | -- | -- | $300K | -- | $400K | $1.33M |
| Net Income | $64.05M | -$19.06M | $5.09M | -$36.56M | -$22.99M | -$11.51M | -$14.36M | -$12.73M | -$10.48M | -$10.96M |
| Basic EPS | $1.53 | -$0.48 | $0.14 | -$0.94 | $0.78 | $0.56 | $0.82 | $0.86 | $0.79 | $0.87 |
| Diluted EPS | $1.50 | -$0.48 | $0.14 | -$0.94 | $0.78 | $0.56 | $0.82 | $0.86 | $0.79 | $0.87 |
| Basic Shares Outstanding | 41.4M | 40.9M | 40.3M | 39.0M | 28.5M | 20.5M | 17.5M | 14.9M | 13.3M | 12.6M |
| Diluted Shares Outstanding | 42.4M | 40.9M | 40.6M | 39.0M | 28.5M | 20.5M | 17.5M | 14.9M | 13.3M | 12.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $0 | $0 | $0 | $2.00M | -- |
| Cost of Revenue | -- | -- | -- | $0 | $0 | $0 | $1.99M | -- |
| Gross Profit | -- | -- | -- | $0 | $0 | $0 | $13K | -- |
| Research & Development | $0 | $0 | $1.59M | $1.99M | $1.15M | $1.03M | $2.21M | $1.46M |
| Operating Income | -$4.10M | -$2.77M | -$3.66M | -$5.67M | -$2.43M | -$2.49M | -$4.50M | -$3.60M |
| EBITDA | -$4.07M | -$2.73M | -$3.63M | -$5.64M | -$2.40M | -$2.46M | -$4.47M | -$3.56M |
| Interest Income | $150K | $98K | $276K | $238K | $510K | $802K | $647K | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | $28.28M | $101.6M | $49.44M | $9.80M | $59.45M | $13.13M | -$7.06M | -$9.78M |
| Income Tax Expense | $9.87M | $23.43M | $11.13M | -$212K | $11.06M | -$126K | $584K | -- |
| Net Income | $18.41M | $78.16M | $38.31M | $10.01M | $48.40M | $13.29M | -$7.64M | -$10.19M |
| Basic EPS | $0.44 | $1.90 | $0.94 | -- | $1.16 | $0.32 | -$0.19 | -- |
| Diluted EPS | $0.43 | $1.84 | $0.91 | -- | $1.13 | $0.31 | -$0.19 | -- |
| Basic Shares Outstanding | 41.7M | 41.0M | 40.8M | -- | 41.8M | 41.7M | 41.2M | -- |
| Diluted Shares Outstanding | 43.0M | 42.5M | 42.0M | -- | 42.8M | 42.6M | 41.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $45.95M | $54.42M | $9.05M | $40.46M | -- | $77.25M | $19.30M | $3.33M | $5.00M | $3.97M |
| Short-Term Investments | $5.42M | $3.44M | $57.71M | $3.74M | $7.75M | $5.85M | $3.30M | $3.70M | $4.59M | $2.86M |
| Cash & Short-Term Investments | $51.36M | $57.86M | $66.77M | $44.21M | -- | $83.10M | $22.59M | $7.03M | $9.59M | $6.83M |
| Total Current Assets | $133.3M | $143.2M | $162.6M | $157.1M | $147.9M | $95.34M | $40.51M | $33.32M | $31.04M | $20.30M |
| Property, Plant & Equipment, Net | $586K | $698K | $873K | $815K | $388K | $397K | $99K | $24K | $17K | $18K |
| Long-Term Investments | $8.37M | $3.52M | $1.81M | $2.70M | $3.88M | $6.69M | $3.93M | $1.29M | $13.54M | $1.0K |
| Other Non-Current Assets | $44K | $32K | $27K | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $97.59M | $12.06M | $57.97M | $4.53M | $29.88M | $32.66M | $4.12M | $1.34M | $16.36M | $18.41M |
| Total Assets | $230.9M | $155.3M | $220.6M | $161.6M | $177.8M | $128.0M | $44.63M | $34.66M | $47.40M | $38.71M |
| Accounts Payable | $443K | $789K | $551K | $2.17M | $1.69M | $2.61M | $594K | $1.34M | $1.14M | $571K |
| Short-Term Debt | -- | -- | $51.01M | -- | -- | -- | -- | $2.70M | $2.45M | -- |
| Deferred Revenue (Current) | $1.35M | -- | -- | $1.34M | $2.00M | -- | $2.70M | $2.70M | $2.45M | $2.45M |
| Other Current Liabilities | $1.71M | $1.37M | $59K | $133K | -- | $243 | -- | -- | -- | -- |
| Total Current Liabilities | $19.09M | $5.68M | $53.21M | $5.75M | $7.37M | $6.68M | $4.54M | $5.31M | $4.55M | $5.17M |
| Long-Term Debt | -- | -- | -- | $25K | $11.62M | $12.54M | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $2.00M | $4.00M | $4.00M | $4.00M | $3.34M | $4.24M | $6.95M | $9.66M | $11.39M | $13.84M |
| Other Non-Current Liabilities | -- | $60K | $63K | -- | -- | -- | $211K | $271K | $313K | $443K |
| Total Non-Current Liabilities | $12.03M | $4.25M | $4.44M | $4.74M | $3.84M | $4.80M | $7.22M | $9.96M | $11.73M | $14.31M |
| Total Liabilities | $31.12M | $9.93M | $57.66M | $10.49M | $11.21M | $11.48M | $11.75M | $15.27M | $16.29M | $19.47M |
| Total Debt (incl. Leases) | $825K | $372K | $51.62M | $919K | $12.12M | $13.08M | $31K | $2.70M | $2.45M | -- |
| Common Stock | $472K | $480K | $485K | $476K | $459K | $424K | $284K | $208K | $207K | $163K |
| Retained Earnings | -$123.4M | -$176.6M | -$157.6M | -$163.1M | -$126.5M | -$114.9M | -$92.61M | -$81.10M | -$69.22M | -$56.50M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | -- | $702K | $401K |
| Total Stockholders' Equity | $199.7M | $146.3M | $163.8M | $151.8M | $166.5M | $115.8M | $32.88M | $19.39M | $31.11M | $19.24M |
| Total Equity | $199.7M | $145.3M | $162.9M | $151.2M | $166.6M | $116.5M | $32.88M | $19.39M | $31.11M | $19.24M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | $15.24M | $13.20M | $45.95M | $52.18M | $15.80M | -- | $54.42M |
| Short-Term Investments | $583K | $846K | $4.96M | $5.42M | $4.96M | $1.75M | $3.69M | $3.44M |
| Cash & Short-Term Investments | -- | $16.09M | $18.17M | $51.36M | $57.13M | $17.55M | -- | $57.86M |
| Total Current Assets | $57.38M | $53.41M | $68.15M | $133.3M | $136.1M | $99.03M | $131.5M | $143.2M |
| Property, Plant & Equipment, Net | $506K | $532K | $561K | $586K | $614K | $645K | $671K | $698K |
| Long-Term Investments | $10.80M | $21.87M | $17.97M | $8.37M | -- | -- | $3.52M | $3.52M |
| Other Non-Current Assets | $46K | $49K | $46K | $44K | $40K | $38K | $32K | $32K |
| Total Non-Current Assets | $343.5M | $316.2M | $200.7M | $97.59M | $84.38M | $62.66M | $16.06M | $12.06M |
| Total Assets | $400.9M | $369.6M | $268.8M | $230.9M | $220.5M | $161.7M | $147.5M | $155.3M |
| Accounts Payable | $125K | $374K | $481K | $443K | $560K | $715K | $509K | $789K |
| Deferred Revenue (Current) | $1.51M | $1.71M | $1.47M | $1.35M | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $1.71M | -- | -- | -- | $1.37M |
| Total Current Liabilities | $9.45M | $10.73M | $10.56M | $19.09M | $6.12M | $3.69M | $5.49M | $5.68M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $2.00M | $2.00M | $2.00M | $2.00M | $4.00M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $60K |
| Total Non-Current Liabilities | $52.39M | $41.44M | $20.01M | $12.03M | $12.04M | $4.41M | $2.15M | $4.25M |
| Total Liabilities | $61.83M | $52.17M | $30.57M | $31.12M | $18.16M | $8.10M | $7.64M | $9.93M |
| Total Debt (incl. Leases) | $1.53M | $733K | $761K | $825K | $860K | $912K | $301K | $372K |
| Common Stock | $519K | $495K | $491K | $472K | $490K | $491K | $491K | $480K |
| Retained Earnings | $11.45M | -$6.96M | -$85.12M | -$123.4M | -$122.6M | -$171.0M | -$184.3M | -$176.6M |
| Total Stockholders' Equity | -- | -- | -- | $199.7M | $203.3M | $154.5M | $140.8M | $146.3M |
| Total Equity | $339.1M | $317.5M | $238.3M | $199.7M | $202.3M | $153.6M | $139.9M | $145.3M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $64.02M | -$19.10M | $5.53M | -$37.76M | -$22.99M | -$11.51M | -$14.36M | -$12.73M | -$10.48M | -$10.96M |
| Depreciation & Amortization | $121K | $193K | $196K | $58K | $77K | $7.0K | $8.0K | $6.0K | $5.0K | $4.0K |
| Stock-Based Compensation | $5.99M | $4.05M | $4.21M | $11.51M | $2.69M | $465K | $808K | $1.55M | $1.57M | $634K |
| Operating Cash Flow | -$9.14M | -$8.41M | -$10.29M | -$27.92M | -$21.18M | -$12.44M | -$12.94M | -$14.66M | -$5.83M | $4.66M |
| Capital Expenditure | -$9.0K | -$18K | -$254K | -$496K | -$375K | -$82K | -$15K | -$5.0K | -$7.0K | -$9.0K |
| Free Cash Flow | -$9.15M | -$8.43M | -$10.55M | -$28.41M | -$21.56M | -$12.52M | -$12.96M | -$14.66M | -$5.84M | $4.65M |
| Purchases of Investments | -$9.85M | -$1.31M | -$99.55M | -- | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | $5.44M | $105.8M | -$73.04M | $30.21M | -$23.76M | $4.63M | $11.26M | -$7.00M | $4.30M | -$16.01M |
| Common Stock Issued | -- | -- | $2.43M | $11.50M | $10.62M | -- | -- | $21.66M | $25K | $10.59M |
| Share Repurchases | -$4.74M | -$2.48M | -- | -- | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | -$4.74M | -$52.04M | $51.98M | $10.78M | $102.9M | $23.79M | -- | $22.65M | $1.59M | $12.04M |
| Net Change in Cash | -$8.47M | $45.37M | -$31.41M | $13.01M | $57.95M | $15.97M | -$1.67M | $1.03M | $62K | $694K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $18.41M | $78.16M | $38.31M | $10.01M | $48.39M | $13.26M | -$7.64M | -$10.20M |
| Depreciation & Amortization | $30K | $31K | $30K | $30K | $31K | $30K | $30K | $31K |
| Stock-Based Compensation | $3.11M | $1.39M | $1.74M | $2.28M | $719K | $800K | $2.19M | $1.23M |
| Operating Cash Flow | $426K | -$200K | -$2.92M | -$466K | -$1.62M | -$3.54M | -$3.52M | -$1.91M |
| Capital Expenditure | -$4.0K | -$2.0K | -$5.0K | -$2.0K | $0 | -$4.0K | -$3.0K | -$11K |
| Free Cash Flow | $422K | -$202K | -$2.92M | -$468K | -$1.62M | -$3.54M | -$3.52M | -$1.92M |
| Purchases of Investments | -$4.21M | -$8.73M | -$12.86M | -- | -- | -$755K | -$1.19M | -- |
| Investing Cash Flow | $13.19M | $4.31M | -$19.49M | -$1.68M | $38.36M | -$54.85M | $23.62M | $15.42M |
| Dividends Paid | -$57K | -$78K | -$10.36M | -- | -- | -- | -- | -- |
| Financing Cash Flow | $40K | -$1.95M | -$10.36M | -- | -- | -- | -- | -$1.20M |
| Net Change in Cash | $13.69M | $2.04M | -$32.74M | -$6.23M | $36.38M | -$58.72M | $20.10M | $12.32M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.7% | -- | -- | -- | -- | -- | 96.7% | 103.5% | 92.4% | 23.6% |
| Operating Margin | -754.4% | -- | -1176.8% | -1502.0% | -896.2% | -433.8% | -541.3% | -552.3% | -438.6% | -1561.6% |
| Net Profit Margin | 3202.5% | -- | 379.7% | -1352.6% | -850.5% | -424.8% | -531.1% | -519.7% | -426.7% | -1710.5% |
| Return on Equity (ROE) | 32.1% | -13.0% | 3.1% | -24.1% | -19.9% | -35.0% | -74.0% | -40.9% | -54.5% | -41.9% |
| Return on Assets (ROA) | 27.7% | -12.3% | 2.3% | -22.6% | -18.0% | -25.8% | -41.4% | -26.9% | -27.1% | -25.6% |
| Current Ratio | 6.98x | 25.19x | 3.06x | 27.34x | 14.27x | 8.93x | 6.28x | 6.82x | 3.93x | 8.62x |
| Quick Ratio | 2.69x | 10.18x | 1.25x | 7.69x | 12.44x | 4.98x | 1.32x | 2.11x | 1.32x | 1.87x |
| Debt to Equity | 0.00x | 0.00x | 0.32x | 0.01x | 0.11x | 0.00x | 0.14x | 0.08x | -- | -- |
| Revenue Growth (YoY) | -- | -- | -50.4% | -- | -0.3% | +0.3% | +10.4% | -0.3% | +283.2% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | +3.1% | +11.7% | +1402.6% | -- |
| Net Income Growth (YoY) | -- | -474.6% | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -442.9% | -- | -- | +39.3% | -31.7% | -4.7% | +8.9% | -9.2% | +29.9% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -225.3% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -225.7% | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | +87.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -245.7% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 0.7% | -- | -- | -- | -- |
| Operating Margin | -- | -- | -- | -754.4% | -- | -- | -- | -- |
| Net Profit Margin | -- | -- | -- | 3202.5% | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | 32.1% | 21.6% | -15.6% | -20.1% | -13.0% |
| Return on Assets (ROA) | 36.1% | 47.3% | 40.9% | 27.7% | 19.9% | -14.9% | -19.1% | -12.3% |
| Current Ratio | 6.07x | 4.98x | 6.45x | 6.98x | 22.24x | 26.81x | 23.94x | 25.19x |
| Quick Ratio | -- | 1.50x | 1.72x | 2.69x | 9.34x | 4.75x | -- | 10.18x |
| Debt to Equity | -- | -- | -- | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |
| Net Income Growth (YoY) | -62.0% | +488.2% | -- | -- | -- | +44.2% | -597.5% | -179.0% |
| EPS Growth (YoY) | -62.1% | +493.7% | -- | -- | -- | +45.5% | -575.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -270.3% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -270.5% | -- | -- |